Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Bruno Fautrel, Alejandro Balsa, Piet Van Riel, Marta Casillas, Jean-Philippe Capron, Carine Cueille & Inmaculada de la Torre. (2017) Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related). Current Medical Research and Opinion 33:7, pages 1231-1246.
Read now
Read now
Vicenç Torrente-Segarra, Ana Urruticoechea Arana, Amalia Sánchez-Andrade Fernández, Juan Víctor Tovar Beltrán, Alejandro Muñoz Jiménez, Anna Martínez-Cristóbal, José Antonio González Ferrández, Manuel Fernández Prada, Noelia Vázquez Fuentes, Hèctor Corominas, Sílvia García-Díaz, Asunción Acosta Pereira, José Miguel Ruiz Martín, José Ramón Lamua Riazuelo, Rosa Expósito Moliner, Desireé Ruiz Vilchez, Raúl Veiga Cabello, Jesús Carlos Fernández, José Raúl Noguera Pons, Noemí Patricia Garrido Puñal, Pedro Giralt Celiméndiz, Raúl Cortés Verdú, Angel Aragón Díez, Carlos Tomás Roura, Concepción Moll Turudi, Delia Taverner Torrent, Felipe Joaquín Rivas Santirso, Juan José Lerma Garrido, Rosa García Portales, Sergi Ordoñez Palau, Silvia Paredes González-Albo, Antonio Gracia Pérez, Arantxa Conesa Mateos, Jaime Calvo Alén, Jenaro Graña Gil, María Pilar Navarro Alonso & María Jesús Martínez Blasco. (2016) study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database. Modern Rheumatology 26:3, pages 336-341.
Read now
Read now
Articles from other publishers (10)
Giulia Cassone, Andreina Manfredi, Caterina Vacchi, Fabrizio Luppi, Francesca Coppi, Carlo Salvarani & Marco Sebastiani. (2020) Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows. Journal of Clinical Medicine 9:4, pages 1082.
Crossref
Crossref
Nobunori Takahashi, Toshihisa Kojima, Daihei Kida, Atsushi Kaneko, Yuji Hirano, Takayoshi Fujibayashi, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Masahiro Hanabayashi, Takefumi Kato, Koji Funahashi, Masatoshi Hayashi, Seiji Tsuboi, Yasuhide Kanayama, Yasumori Sobue, Nobuyuki Asai, Takuya Matsumoto, Tatsuo Watanabe, Shuji Asai & Naoki Ishiguro. (2019) Concomitant methotrexate has little effect on clinical outcomes of abatacept in rheumatoid arthritis: a propensity score matching analysis. Clinical Rheumatology 38:9, pages 2451-2459.
Crossref
Crossref
Ayako Nishino, Shin‐ya Kawashiri, Tomohiro Koga, Naoki Iwamoto, Kunihiro Ichinose, Mami Tamai, Hideki Nakamura, Tomoki Origuchi, Yukitaka Ueki, Tamami Yoshitama, Nobutaka Eiraku, Naoki Matsuoka, Akitomo Okada, Keita Fujikawa, Hiroaki Hamada, Tomomi Tsuru, Shuji Nagano, Yojiro Arinobu, Toshihiko Hidaka & Atsushi Kawakami. (2018) Ultrasonographic Efficacy of Biologic and Targeted Synthetic Disease‐Modifying Antirheumatic Drug Therapy in Rheumatoid Arthritis From a Multicenter Rheumatoid Arthritis Ultrasound Prospective Cohort in Japan. Arthritis Care & Research 70:12, pages 1719-1726.
Crossref
Crossref
Einav Srulovici, Vishvas Garg, Adi Ghilai, Becca Feldman, Moshe Hoshen, Ran D. Balicer, Martha Skup & Maya Leventer-Roberts. (2018) Is Patient Support Program Participation Associated with Longer Persistence and Improved Adherence Among New Users of Adalimumab? A Retrospective Cohort Study. Advances in Therapy 35:5, pages 655-665.
Crossref
Crossref
Tsutomu Takeuchi, Ryo Nakajima, Shuichi Komatsu, Kiyotaka Yamazaki, Tomohiro Nakamura, Naoki Agata, Ataru Igarashi, Toshiro Tango & Yoshiya Tanaka. (2017) Impact of Adalimumab on Work Productivity and Activity Impairment in Japanese Patients with Rheumatoid Arthritis: Large-Scale, Prospective, Single-Cohort ANOUVEAU Study. Advances in Therapy 34:3, pages 686-702.
Crossref
Crossref
Yosuke Hattori, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Yuji Hirano, Takayoshi Fujibayashi, Kenya Terabe, Yuichiro Yabe, Hiroyuki Miyake, Takefumi Kato, Hideki Takagi, Masatoshi Hayashi, Takayasu Ito, Yasuhide Kanayama, Takeshi Oguchi, Nobunori Takahashi, Hisato Ishikawa, Koji Funahashi & Naoki Ishiguro. (2016) Longterm Retention Rate and Risk Factors for Adalimumab Discontinuation Due To Efficacy and Safety in Japanese Patients with Rheumatoid Arthritis: An Observational Cohort Study. The Journal of Rheumatology 43:8, pages 1475-1479.
Crossref
Crossref
Nobunori Takahashi, Takayoshi Fujibayashi, Daihei Kida, Yuji Hirano, Takefumi Kato, Daizo Kato, Kiwamu Saito, Atsushi Kaneko, Yuichiro Yabe, Hideki Takagi, Takeshi Oguchi, Hiroyuki Miyake, Tsuyoshi Watanabe, Masatoshi Hayashi, Yasuhide Kanayama, Koji Funahashi, Masahiro Hanabayashi, Shinya Hirabara, Shuji Asai, Toki Takemoto, Kenya Terabe, Nobuyuki Asai, Yutaka Yoshioka, Naoki Ishiguro & Toshihisa Kojima. (2015) Concomitant methotrexate and tacrolimus augment the clinical response to abatacept in patients with rheumatoid arthritis with a prior history of biological DMARD use. Rheumatology International 35:10, pages 1707-1716.
Crossref
Crossref
N. Takahashi, T. Kojima, A. Kaneko, D. Kida, Y. Hirano, T. Fujibayashi, Y. Yabe, H. Takagi, T. Oguchi, H. Miyake, T. Kato, N. Fukaya, M. Hayashi, S. Tsuboi, Y. Kanayama, K. Funahashi, M. Hanabayashi, S. Hirabara, S. Asai, Y. Yoshioka & N. Ishiguro. (2014) Use of a 12-week observational period for predicting low disease activity at 52 weeks in RA patients treated with abatacept: a retrospective observational study based on data from a Japanese multicentre registry study. Rheumatology 54:5, pages 854-859.
Crossref
Crossref
Shunsuke MoriYukinori KogaMineharu Sugimoto. (2015) Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based Review. Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine 9s1, pages CCRPM.S23327.
Crossref
Crossref
Hiroyuki Matsubara, Toshihisa Kojima, Atsushi Kaneko, Yuji Hirano, Hisato Ishikawa, Yousuke Hattori, Hiroyuki Miyake, Takeshi Oguchi, Hideki Takagi, Yuichiro Yabe, Takefumi Kato, Takayasu Ito, Naoki Fukaya, Yasuhide Kanayama, Tomone Shioura, Masatoshi Hayashi, Takayoshi Fujibayashi, Nobunori Takahashi, Koji Funahashi, Daizo Kato, Masahiro Hanabayashi, Kenya Terabe & Naoki Ishiguro. (2014) Longterm Retention Rate and Risk Factor for Discontinuation Due to Insufficient Efficacy and Adverse Events in Japanese Patients with Rheumatoid Arthritis Receiving Etanercept Therapy. The Journal of Rheumatology 41:8, pages 1583-1589.
Crossref
Crossref